Linking Researchers and Industry
- The Avicenna Alliance is dedicated to ensuring the full innovation cycle of predictive medicine is represented.
- The Virtual Physiological Human (VPH) Initiative, carries a non-diminishable 50% board representation on the Avicenna Alliance with Industry representatives from Medical Devices, Pharmaceuticals and Software also maintaining a 50% board membership.
- The VPH Institute is a massive network of Research Organisations and Universities engaged in predictive or in silico medicine. The VPH Institute has its origins as an EU funded DG Connect project and has been active for over 10 years.
- This partnership of industry and researchers allows the Avicenna Alliance to address challenges to the predictive or in silico market from pre-clinical research all the way to post-market.